-
A02111-40
Anti-Palivizumab Antibody (2F12), mAb, Mouse,40 g
Price: $364.06List Price: $404.52Palivizumab with trade name Synagis, is an FDA-approved drug for the prevention of respiratory syncytial virus (RSV) infections. It is a recombinant humanized IgG1 kappa isotype monoclonal antibody. -
A02112-40
Anti-Palivizumab Antibody (7B3), mAb, Mouse,40 g
Price: $364.06List Price: $404.52Palivizumab with trade name Synagis, is an FDA-approved drug for the prevention of respiratory syncytial virus (RSV) infections. It is a recombinant humanized IgG1 kappa isotype monoclonal antibody. -
HPA001936-100
Anti-PNMA2 paraneoplastic Ma antigen 2, 100ul UN 1687 6.1 PG
Price: $1,045.96List Price: $1,162.18Anti-PNMA2 paraneoplastic Ma antigen 2, 100ul UN 1687 6.1 PG -
HPA001936-25
Anti-PNMA2 paraneoplastic Ma antigen 2, 25ul UN 1687 6.1 PG2
Price: $745.62List Price: $828.46Anti-PNMA2 paraneoplastic Ma antigen 2, 25ul UN 1687 6.1 PG2 -
ITA3321-100u
Immunotag™ LAMA5 Antibody* (C009B-090253)
Price: $567.91List Price: $631.01Immunotag™ LAMA5 Antibody* -
ITA3321-200u
Immunotag™ LAMA5 Antibody* (C009B-090263)
Price: $708.48List Price: $787.20Immunotag™ LAMA5 Antibody* -
L0130000
LACTULOSE EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD (C005B-250698)
Price: $304.24List Price: $338.05General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the -
Ab170474-100μg
Motavizumab (anti-RSV-F) (C007B-327457)
Price: $155.60List Price: $172.88Motavizumab is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg. -
Ab170474-10mg
Motavizumab (anti-RSV-F) (C007B-327458)
Price: $1,996.25List Price: $2,218.05Motavizumab is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg. -
Ab170474-1mg
Motavizumab (anti-RSV-F) (C007B-327459)
Price: $540.15List Price: $600.17Motavizumab is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg. -
Ab170474-5mg
Motavizumab (anti-RSV-F) (C007B-327460)
Price: $1,237.99List Price: $1,375.54Motavizumab is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg.